Stocksigma LogoStocksigma Logo

Natural Biocon Defers Q2 Results, Appoints MD, and Schedules AGM

Natural Biocon (India) Limited deferred the approval of its unaudited standalone financial results for the quarter ended 30th Sep'26 due to pending audit

Natural Biocon Defers Q2 Results, Appoints MD, and Schedules AGM

Natural Biocon (India) Ltd 路 Outcome 路 14 Nov 2026, 11:57 pm

Natural Biocon Defers Q2 Results, Appoints MD, and Schedules AGM Natural Biocon (India) Limited deferred the approval of its unaudited standalone financial results for the quarter ended 30th Sep'26 due to pending audit matters. The Board approved the appointment of Archana Chaitanya Pandya as Managing Director for a five-year term effective 14th Nov'26 to 13th Nov'31, and Kalpana Srinivasan as Secretarial Auditor for FY26鈥揊Y30, both subject to shareholder approval. Following a RoC extension, the 34th AGM is scheduled for 14th Dec'26, with share transfer books closed from 8th Dec'26 to 14th Dec'26.

Original exchange filing (PDF)

More announcements from Natural Biocon (India) Ltd

All Natural Biocon (India) Ltd announcements